Cargando…

Role of altered esophageal intraluminal baseline impedance levels in patients with gatroesophageal reflux disease refractory to proton pump inhibitors

Numerous studies have investigated utility of esophageal intraluminal baseline impedance levels (BILs) in gastroesophageal reflux disease (GERD). However, effect of BILs in refractory GERD (RGERD) has not been well investigated. The aim of this study is to evaluate role of BILs in RGERD patients. To...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Liuqin, Ye, Bixing, Lin, Lin, Wang, Ying, Wang, Meifeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2016
Materias:	4500
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5370788/ https://www.ncbi.nlm.nih.gov/pubmed/27537561 http://dx.doi.org/10.1097/MD.0000000000004351

Ejemplares similares

Esophageal Nocturnal Baseline Impedance and Post-reflux Swallow-induced Peristaltic Wave Index in Identifying Proton Pump Inhibitor-refractory Non-erosive Reflux Disease
por: Wang, Yan, et al.
Publicado: (2021)

Reflux episodes and esophageal impedance levels in patients with typical and atypical symptoms of gastroesophageal reflux disease
por: Ye, Bi Xing, et al.
Publicado: (2017)

Sex-Based Differences in pH Parameters and Esophageal Impedance of Patients With Gastroesophageal Reflux Disease
por: Ye, Bixing, et al.
Publicado: (2021)

Esophageal Body Motility for Clinical Assessment in Patients with Refractory Gastroesophageal Reflux Symptoms
por: Jiang, Liuqin, et al.
Publicado: (2017)

Efficacy of vonoprazan for initial and maintenance therapy in reflux esophagitis, nonerosive esophagitis, and proton pump inhibitor-resistant gastroesophageal reflux disease
por: Gotoh, Yasuhiko, et al.
Publicado: (2020)

Esophageal intraluminal baseline impedance is associated with severity of acid reflux and epithelial structural abnormalities in patients with gastroesophageal reflux disease
por: Zhong, Chanjuan, et al.
Publicado: (2012)

Factors of Reflux Episodes With Post-reflux Swallow-induced Peristaltic Wave in Gastroesophageal Reflux Disease
por: Xu, Hairong, et al.
Publicado: (2020)

An analysis of 342 patients with refractory gastroesophageal reflux disease symptoms using questionnaires, high-resolution manometry, and impedance-pH monitoring
por: Wang, Fei, et al.
Publicado: (2017)

Can Esophageal Baseline Impedance Predict Proton Pump Inhibitor Response in Gastroesophageal Reflux Disease?
por: Jung, Kyoungwon, et al.
Publicado: (2018)

Randomized Controlled Trial of Anti-reflux Mucosectomy Versus Radiofrequency Energy Delivery for Proton Pump Inhibitor-refractory Gastroesophageal Reflux Disease
por: Wang, Yan, et al.
Publicado: (2023)

Stretta procedure versus proton pump inhibitors for the treatment of nonerosive reflux disease: A 6-month follow-up
por: He, Suyu, et al.
Publicado: (2020)

Clinical and endoscopic characteristics of acute esophageal necrosis and severe reflux esophagitis
por: Okamoto, Takeshi, et al.
Publicado: (2021)

Ineffective esophageal motility assessment in patients with and without pathological esophageal acid reflux
por: Pakoz, Zehra Betul, et al.
Publicado: (2021)

Physicians and Patients Measure Different Dimension on Assessment for Gatroesophageal Reflux Disease-Related Symptoms
por: Lopez-Alvarenga, Juan Carlos, et al.
Publicado: (2011)

Reflux esophagitis in patients with chronic obstructive pulmonary disease
por: Kang, Hyeon Hui, et al.
Publicado: (2021)

Severe reflux esophagitis and multiple congenital defects: A case report
por: Ma, Jia-Yi, et al.
Publicado: (2020)

Association between proton pump inhibitors and hepatic encephalopathy: A meta-analysis
por: Bian, Jin, et al.
Publicado: (2017)

Corrigendum: Physicians and Patients Measure Different Dimension on Assessment for Gatroesophageal Reflux Disease-related Symptoms
por: Lopez-Alvarenga, Juan Carlos, et al.
Publicado: (2012)

Comparative effectiveness and acceptability of the FDA-licensed proton pump inhibitors for erosive esophagitis: A PRISMA-compliant network meta-analysis
por: Li, Mei-Juan, et al.
Publicado: (2017)

Increased TRPV1 and PAR2 mRNA expression levels are associated only with the esophageal reflux symptoms, but not with the extraesophageal reflux symptoms
por: Kim, Jin Joo, et al.
Publicado: (2016)

The prevalence of coronary atherosclerosis in patients with refractory gastroesophageal reflux disease ready for antireflux surgery
por: Zhang, Xiumei, et al.
Publicado: (2022)

Use of proton pump inhibitors for the risk of gastric cancer
por: Gao, Huiqin, et al.
Publicado: (2022)

Efficacy and safety of proton pump inhibitors versus vonoprazan in treatment of erosive esophagitis: A PRISMA-compliant systematic review and network meta-analysis
por: Yang, Sensen, et al.
Publicado: (2022)

Laparoscopic fundoplication in treating refractory gastroesophageal reflux-related chronic cough: A meta-analysis
por: Liu, Jiannan, et al.
Publicado: (2023)

Mean nocturnal baseline impedance, a novel metric of multichannel intraluminal impedance-pH monitoring in diagnosing gastroesophageal reflux disease
por: Wu, Yanhong, et al.
Publicado: (2022)

Rebamipide Plus Proton Pump Inhibitor Versus Proton Pump Inhibitor Alone in the Treatment of Endoscopic Submucosal Dissection-Induced Gastric Ulcer: Retracted: A Meta-Analysis of Randomized Controlled Trials
por: Xiong, Ji, et al.
Publicado: (2014)

Esophageal Bolus Transit in Newborns with Gastroesophageal Reflux Disease Symptoms: A Multichannel Intraluminal Impedance Study
por: Cresi, Francesco, et al.
Publicado: (2015)

Laparoscopic Nissen (total) versus anterior 180° fundoplication for gastro-esophageal reflux disease: A meta-analysis and systematic review
por: Du, Xing, et al.
Publicado: (2017)

Impedance pH Guided Approach to Proton Pump Inhibitor-refractory Non-erosive Reflux Disease
por: Cho, Yu Kyung
Publicado: (2014)

Tailored therapy guided by multichannel intraluminal impedance pH monitoring for refractory non-erosive reflux disease
por: Ranaldo, Nunzio, et al.
Publicado: (2017)

Celiac disease serology and gut microbiome following proton pump inhibitor treatment
por: Jang, Sophie, et al.
Publicado: (2020)

Eosinophilic esophagitis in patients with typical gastroesophageal reflux disease symptoms refractory to proton pump inhibitor
por: de Sá, Cláudia Cristina, et al.
Publicado: (2011)

Proton pump inhibitor use is associated with a variety of infections in patients with liver cirrhosis
por: Labenz, Christian, et al.
Publicado: (2020)

Impaired Esophageal Mucosal Integrity May Play a Causative Role in Patients With Nongastroesophageal Reflux Disease–Related Noncardiac Chest Pain
por: Min, Yang Won, et al.
Publicado: (2015)

Salivary peptest for laryngopharyngeal reflux and gastroesophageal reflux disease: A systemic review and meta-analysis
por: Guo, Zihao, et al.
Publicado: (2021)

Validation of Pharyngeal Acid Reflux Episodes Using Hypopharyngeal Multichannel Intraluminal Impedance-pH
por: Chen, Yen-Yang, et al.
Publicado: (2023)

Esophageal Baseline Impedance Reflects Mucosal Integrity and Predicts Symptomatic Outcome With Proton Pump Inhibitor Treatment
por: Xie, Chenxi, et al.
Publicado: (2018)

Effectiveness and safety of proton pump inhibitors for treating acute pancreatitis: A protocol for systematic review and meta analysis
por: Cheng, Tao, et al.
Publicado: (2021)

Influence of individual proton pump inhibitors on clinical outcomes in patients receiving clopidogrel following percutaneous coronary intervention
por: Lee, Dongyoung, et al.
Publicado: (2021)

Peroral endoscopic cardial constriction in gastroesophageal reflux disease
por: Hu, Hai-Qing, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_sf1ji2oh894p7aep2i0eaofb7q